Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,136,581 papers from all fields of science
Search
Sign In
Create Free Account
Apolipoprotein A5 Measurement
Known as:
APOA5
, Apolipoprotein A5
The determination of the amount of the apolipoprotein A5 in a sample.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Apolipoprotein A5
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Association of the Apolipoprotein A5 Gene −1131T>C Polymorphism with Serum Lipids in Korean Subjects: Impact of Sasang Constitution
K. Song
,
Sung-Gon Yu
,
Seongwon Cha
,
J. Y. Kim
Evidence-Based Complementary and Alternative…
2011
Corpus ID: 9560992
Apolipoprotein A5 (APOA5) was identified as a strong modulator of serum lipids. Moreover, an APOA5 gene −1131T>C polymorphism has…
Expand
2011
2011
Association of GWAS-based candidate genes with HDL-cholesterol levels before and after bariatric surgery in the Swedish obese subjects study.
M. Sarzynski
,
P. Jacobson
,
+4 authors
C. Bouchard
Journal of Clinical Endocrinology and Metabolism
2011
Corpus ID: 42261775
CONTEXT AND OBJECTIVE The magnitude of weight loss-induced high-density lipoprotein cholesterol (HDL-C) changes may depend on…
Expand
2010
2010
Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Zhi-kai Liu
,
Miao Hu
,
L. Baum
,
G. Thomas
,
B. Tomlinson
Atherosclerosis
2010
Corpus ID: 22738808
Highly Cited
2008
Highly Cited
2008
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia
Jian Wang
,
M. Ban
,
+5 authors
R. Hegele
Nature Clinical Practice Cardiovascular Medicine
2008
Corpus ID: 13393729
Background Several known candidate gene variants are useful markers for diagnosing hyperlipoproteinemia. In an attempt to…
Expand
2008
2008
Determinants of plasma apolipoprotein A‐V and APOA5 gene transcripts in humans
Penelope Hahne
,
F. Krempler
,
+6 authors
W. Patsch
Journal of Internal Medicine
2008
Corpus ID: 22887075
Objective. Apolipoprotein A‐V (apoAV) contributes to the regulation of triglyceride metabolism, which plays a role in the…
Expand
2008
2008
Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
S. Charrière
,
S. Bernard
,
+7 authors
C. Marçais
Clinica chimica acta; international journal of…
2008
Corpus ID: 40390173
Highly Cited
2007
Highly Cited
2007
Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
P. Henneman
,
F. Schaap
,
+6 authors
K. W. van Dijk
Atherosclerosis
2007
Corpus ID: 25775560
2007
2007
The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
B. Dorfmeister
,
J. Cooper
,
+4 authors
P. Talmud
Biochimica et Biophysica Acta
2007
Corpus ID: 35835879
2007
2007
Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
G. M. van der Vleuten
,
A. Isaacs
,
+6 authors
J. de Graaf
Biochimica et Biophysica Acta
2007
Corpus ID: 24738571
2005
2005
Apolipoprotein A5 gene polymorphism –1131T→C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese
Sheng-kai Yan
,
Xin-qi Cheng
,
Yao-hong Song
,
Xin-Hua Xiao
,
N. Bi
,
Bao-sheng Chen
Clinical Chemistry and Laboratory Medicine
2005
Corpus ID: 32030847
Abstract Type 2 diabetes mellitus (DM) is associated with significant abnormalities of lipoprotein metabolism and coronary heart…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE